Analysis of the Levels of HLADR+ Extracellular Vesicles in Women With Preeclampsia as a Early Potential Biomarker
NCT ID: NCT06873737
Last Updated: 2025-03-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
300 participants
INTERVENTIONAL
2022-09-01
2026-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Placental Inflammation in Gestational Diabetes
NCT06884696
Biomarkers of CVD Dysfunction in Hypertensive Disorders of Pregnancy
NCT05806372
Evaluation of Patients With Hypertensive Disorders of Pregnancy: An Ambispective Observational Study
NCT07299773
Identifying Biomarkers for Endothelial Dysfunction in Women With Preeclampsia
NCT07084727
A Novel Multiomic AI Approach for Early Preeclampsia Prediction in Pregnancy
NCT06430398
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
"High risk"
Blood sampling from women with high risk to develop preeclampsia in the first, second and third trimester of pregnancy
Blood samples for inflammatory markers
Blood sampling in the first, second, trimester of pregnancy
Low risk
Blood sampling from women with low risk to develop preeclampsia in the first, second and third trimester of pregnancy
Blood samples for inflammatory markers
Blood sampling in the first, second, trimester of pregnancy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood samples for inflammatory markers
Blood sampling in the first, second, trimester of pregnancy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged \> 18 years
Exclusion Criteria
* women unable to give informed consent
* infectious diseases
* twin pregnancies
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chiara Tersigni
Role: PRINCIPAL_INVESTIGATOR
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondazione Policlinico Universitario Agostino Gemelli
Rome, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4299
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.